Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 01
2025
|
Jami K Nachtsheim Director |
SELL
Open market or private sale
|
Direct |
2,400
-27.36%
|
$1,248,000
$520.0 P/Share
|
|
May 01
2025
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,400
+21.48%
|
$216,000
$90.49 P/Share
|
|
Apr 30
2025
|
Amy L Ladd Director |
SELL
Open market or private sale
|
Direct |
8,776
-55.12%
|
$4,431,880
$505.55 P/Share
|
|
Apr 30
2025
|
Amy L Ladd Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,776
+35.5%
|
$2,044,808
$233.6 P/Share
|
|
Apr 29
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
188
-3.47%
|
$96,256
$512.9 P/Share
|
|
Apr 29
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
188
+3.36%
|
$39,104
$208.9 P/Share
|
|
Apr 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
188
-3.47%
|
$96,820
$515.91 P/Share
|
|
Apr 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
188
+3.36%
|
$54,520
$290.33 P/Share
|
|
Apr 25
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
614
-2.85%
|
$314,982
$513.18 P/Share
|
|
Apr 25
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
614
+2.77%
|
$158,412
$258.32 P/Share
|
|
Apr 25
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-91.89%
|
$2,052,000
$513.18 P/Share
|
|
Apr 25
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+47.89%
|
$968,000
$242.34 P/Share
|
|
Apr 25
2025
|
Gary Loeb EVP & Chief Legal and Complian |
SELL
Open market or private sale
|
Direct |
1,700
-43.09%
|
$872,100
$513.18 P/Share
|
|
Apr 25
2025
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+10.39%
|
-
|
|
Apr 25
2025
|
Lewis Chew Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+48.55%
|
-
|
|
Apr 25
2025
|
Amal M Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+5.37%
|
-
|
|
Apr 25
2025
|
Monica P Reed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+23.96%
|
-
|
|
Apr 25
2025
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,043
+3.69%
|
-
|
|
Apr 25
2025
|
Amy L Ladd Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+34.39%
|
-
|
|
Apr 25
2025
|
Sreelakshmi Kolli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+43.02%
|
-
|
|
Apr 25
2025
|
Keith R Leonard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+23.96%
|
-
|
|
Apr 25
2025
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+4.22%
|
-
|
|
Apr 25
2025
|
Joseph C Beery Director |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+19.2%
|
-
|
|
Mar 13
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
11,545
-12.18%
|
$5,749,410
$498.87 P/Share
|
|
Mar 13
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
3,281
+3.75%
|
$889,151
$271.05 P/Share
|
|
Mar 12
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Open market or private sale
|
Direct |
4,000
-25.53%
|
$2,048,000
$512.06 P/Share
|
|
Mar 12
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+20.24%
|
$772,000
$193.45 P/Share
|
|
Mar 11
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Open market or private sale
|
Direct |
8,900
-23.15%
|
$4,307,600
$484.58 P/Share
|
|
Mar 11
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,834
+11.12%
|
$324,618
$177.99 P/Share
|
|
Mar 07
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
489
-18.95%
|
$260,637
$533.18 P/Share
|
|
Mar 06
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-16.02%
|
$274,536
$558.95 P/Share
|
|
Mar 05
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-13.8%
|
$272,568
$554.17 P/Share
|
|
Mar 05
2025
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
16,509
-3.49%
|
$9,195,513
$557.52 P/Share
|
|
Mar 05
2025
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,250
+5.81%
|
$1,989,000
$68.23 P/Share
|
|
Mar 04
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-12.13%
|
$276,996
$563.69 P/Share
|
|
Mar 03
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-10.82%
|
$281,916
$573.78 P/Share
|
|
Mar 03
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,031
-89.57%
|
$1,748,887
$577.3 P/Share
|
|
Mar 03
2025
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
810
-63.13%
|
$464,130
$573.78 P/Share
|
|
Feb 28
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
2,610
-19.21%
|
$1,469,430
$563.77 P/Share
|
|
Feb 28
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
877
+10.91%
|
-
|
|
Feb 28
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,983
-25.08%
|
$1,679,429
$563.77 P/Share
|
|
Feb 28
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,002
+13.6%
|
-
|
|
Feb 28
2025
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-15.37%
|
$131,179
$563.77 P/Share
|
|
Feb 28
2025
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+23.59%
|
-
|
|
Feb 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
3,553
-10.74%
|
$2,000,339
$563.77 P/Share
|
|
Feb 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,504
+8.11%
|
-
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Open market or private sale
|
Direct |
188
-1.3%
|
$106,408
$566.94 P/Share
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
940
+3.32%
|
$156,040
$166.41 P/Share
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Payment of exercise price or tax liability
|
Direct |
2,238
-12.31%
|
$1,259,994
$563.77 P/Share
|
|
Feb 28
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
2,020
-10.6%
|
$1,137,260
$563.77 P/Share
|